News
Becton, Dickinson (NYSE:BDX) declares $1.04/share quarterly dividend, in line with previous. Forward yield 2.29% Payable Sept. 30; for shareholders of record Sept. 8; ex-div Sept. 8. See BDX Dividend ...
Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 ...
This was the stock's second consecutive day of losses.
Life sciences firm Waters will take on $4 billion in debt, and issue 39.2% of its shares to Becton Dickinson shareholders.
Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A ...
Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...
Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...
Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for around $17.5 ...
Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” second quarter 2025 ...
Medical analysis equipment maker Waters is combining with a unit of Becton Dickinson in a complex spin-merge. At a discount ...
Dividend stocks that reliably increase their dividends are the perfect pick for income investors. Buying reliable dividend ...
Becton Dickinson said production of its recently approved rapid test for the coronavirus strain Covid-19 will ramp up to 12 million tests per month by the end of February 2021.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results